Vanguard Group Inc Verve Therapeutics, Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Verve Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 4,005,161 shares of VERV stock, worth $18.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,005,161

Previous 5,263,509 23.91%

Holding current value

$18.4 Million

Previous $25.7 Million 24.53%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$4.4 - $7.86 $5.54 Million - $9.89 Million	-1,258,348 Reduced 23.91%	4,005,161 $19.4 Million
Q2 2024 Aug 13, 2024	SELL	$4.76 - $12.79 $5.08 Million - $13.7 Million	-1,067,803 Reduced 16.87%	5,263,509 $25.7 Million
Q1 2024 May 10, 2024	BUY	$10.81 - $17.96 $9.29 Million - $15.4 Million	859,382 Added 15.71%	6,331,312 $84.1 Million
Q4 2023 Feb 14, 2024	BUY	$8.84 - $18.7 $5.65 Million - $11.9 Million	638,962 Added 13.22%	5,471,930 $76.3 Million
Q3 2023 Nov 14, 2023	BUY	$11.42 - $20.82 $8.47 Million - $15.4 Million	741,753 Added 18.13%	4,832,968 $64.1 Million
Q2 2023 Aug 14, 2023	BUY	$13.34 - $19.9 $2.83 Million - $4.23 Million	212,365 Added 5.47%	4,091,215 $76.7 Million
Q1 2023 May 15, 2023	BUY	$14.3 - $24.01 $955,611 - $1.6 Million	66,826 Added 1.75%	3,878,850 $55.9 Million
Q4 2022 Feb 10, 2023	BUY	$17.85 - $40.7 $2.73 Million - $6.24 Million	153,212 Added 4.19%	3,812,024 $73.8 Million
Q3 2022 Nov 14, 2022	BUY	$15.63 - $41.49 $20.6 Million - $54.6 Million	1,316,619 Added 56.21%	3,658,812 $126 Million
Q2 2022 Aug 12, 2022	BUY	$11.14 - $23.17 $260,876 - $542,595	23,418 Added 1.01%	2,342,193 $35.8 Million
Q1 2022 May 13, 2022	BUY	$20.92 - $39.36 $20 Million - $37.6 Million	954,554 Added 69.97%	2,318,775 $52.9 Million
Q4 2021 Feb 14, 2022	BUY	$31.94 - $54.82 $2.61 Million - $4.48 Million	81,679 Added 6.37%	1,364,221 $50.3 Million
Q3 2021 Nov 12, 2021	BUY	$46.0 - $73.99 $56 Million - $90.1 Million	1,217,542 Added 1873.14%	1,282,542 $60.3 Million
Q2 2021 Aug 13, 2021	BUY	$31.92 - $60.25 $2.07 Million - $3.92 Million	65,000 New	65,000 $3.92 Million

Others Institutions Holding VERV

# of Institutions

186

Shares Held

73.3M

Call Options Held

85K

Put Options Held

215K

View Full List

About Verve Therapeutics, Inc.

Ticker VERV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,942,300
Market Cap $276M
Description
Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...

More about VERV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Verve Therapeutics, Inc. Transaction History